| scholarly article | Q13442814 |
| P50 | author | Robert K Ernst | Q56259631 |
| P2093 | author name string | Sunil Amin | |
| Valerie J Waters | |||
| Alice Prince | |||
| Grace Soong | |||
| Marisa I Gómez | |||
| P2860 | cites work | Role of the type 1 TNF receptor in lung inflammation after inhalation of endotoxin or Pseudomonas aeruginosa. | Q44451030 |
| Contemporary in vitro spectrum of activity summary for antimicrobial agents tested against 18569 strains non-fermentative Gram-negative bacilli isolated in the SENTRY Antimicrobial Surveillance Program (1997-2001). | Q44682711 | ||
| Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa. | Q44912919 | ||
| Suspected ventilator-associated pneumonia in cardiac patients admitted to the coronary care unit | Q47649237 | ||
| Significance of positive Stenotrophomonas maltophilia culture in acute respiratory tract infection | Q47805223 | ||
| Detecting Stenotrophomonas maltophilia does not reduce survival of patients with cystic fibrosis. | Q51708622 | ||
| Improved Preparation of Lipoteichoic Acids | Q52499079 | ||
| Bacterial colonisation with Xanthomonas maltophilia--a retrospective study in a cystic fibrosis patient population. | Q54200267 | ||
| Detergent-accelerated hydrolysis of bacterial endotoxins and determination of the anomeric configuration of the glycosyl phosphate present in the "isolated lipid A" fragment of the Bordetella pertussis endotoxin | Q69922037 | ||
| Risk factors for emergence of Stenotrophomonas maltophilia in cystic fibrosis | Q73912840 | ||
| Stenotrophomonas maltophilia interaction with human epithelial respiratory cells in vitro | Q74603293 | ||
| Acute necrotizing ulcerative gingivitis and bacteremia caused by Stenotrophomonas maltophilia in an immunocompromised host | Q81383662 | ||
| Prospective evaluation of emerging bacteria in cystic fibrosis | Q81488171 | ||
| Trimethoprim-sulfamethoxazole in the treatment of Stenotrophomonas maltophilia osteomyelitis | Q81673157 | ||
| Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia | Q24533461 | ||
| Staphylococcus aureus protein A induces airway epithelial inflammatory responses by activating TNFR1 | Q28271523 | ||
| Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa | Q28492663 | ||
| Role of flagella in pathogenesis of Pseudomonas aeruginosa pulmonary infection | Q28493023 | ||
| Bacterial biofilms: from the natural environment to infectious diseases | Q29547677 | ||
| Biofilm formation as microbial development | Q29619202 | ||
| Structures of the O4 and O18 antigens of Stenotrophomonas maltophilia: a case of enantiomeric repeating units | Q32058990 | ||
| Factors affecting the incidence of Stenotrophomonas maltophilia isolation in cystic fibrosis | Q34686580 | ||
| Bacterial neuraminidase facilitates mucosal infection by participating in biofilm production | Q34803233 | ||
| Nonopsonic phagocytosis of Pseudomonas aeruginosa by macrophages and polymorphonuclear leukocytes requires the presence of the bacterial flagellum | Q35451910 | ||
| Contribution of specific Pseudomonas aeruginosa virulence factors to pathogenesis of pneumonia in a neonatal mouse model of infection | Q35460765 | ||
| Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis | Q35557791 | ||
| LPS, TLR4 and infectious disease diversity. | Q35988748 | ||
| Pathogen-host interactions in Pseudomonas aeruginosa pneumonia | Q36032639 | ||
| High genetic diversity among Stenotrophomonas maltophilia strains despite their originating at a single hospital | Q36239995 | ||
| Flagellar activation of epithelial signaling | Q36378780 | ||
| Stenotrophomonas maltophilia bacteremia in burn patients | Q36382855 | ||
| Characterization of flagella produced by clinical strains of Stenotrophomonas maltophilia | Q37320289 | ||
| Activation of NF-kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells | Q37383069 | ||
| Lipopolysaccharide (LPS) from Burkholderia cepacia is more active than LPS from Pseudomonas aeruginosa and Stenotrophomonas maltophilia in stimulating tumor necrosis factor alpha from human monocytes. | Q39510228 | ||
| Pseudomonas aeruginosa cell-to-cell signaling is required for virulence in a model of acute pulmonary infection | Q39538040 | ||
| Role of phosphoglucomutase of Stenotrophomonas maltophilia in lipopolysaccharide biosynthesis, virulence, and antibiotic resistance | Q39755193 | ||
| Chemistry and immunochemistry of bacterial lipopolysaccharides as cell wall antigens and endotoxins | Q40105951 | ||
| Biofilm formation by Stenotrophomonas maltophilia: modulation by quinolones, trimethoprim-sulfamethoxazole, and ceftazidime. | Q40410432 | ||
| Pseudomonas aeruginosa lipid A diversity and its recognition by Toll-like receptor 4. | Q40597639 | ||
| Cystic fibrosis pathogens activate Ca2+-dependent mitogen-activated protein kinase signaling pathways in airway epithelial cells | Q40817343 | ||
| The major extracellular protease of the nosocomial pathogen Stenotrophomonas maltophilia: characterization of the protein and molecular cloning of the gene | Q43858108 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | infectious disease | Q18123741 |
| Stenotrophomonas maltophilia | Q142705 | ||
| emerging pathogen | Q108429945 | ||
| P304 | page(s) | 1698-703 | |
| P577 | publication date | 2007-04-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Immunostimulatory properties of the emerging pathogen Stenotrophomonas maltophilia | |
| P478 | volume | 75 |
| Q35146935 | Abattoirs as non-hospital source of extended spectrum beta lactamase producers: confirmed by the double disc synergy test and characterized by matrix-assisted laser desorption/ionization time of flight mass spectrometry |
| Q34806726 | Abundance of the Quorum-Sensing Factor Ax21 in Four Strains of Stenotrophomonas maltophilia Correlates with Mortality Rate in a New Zebrafish Model of Infection |
| Q33331700 | Acyl chain specificity of the acyltransferases LpxA and LpxD and substrate availability contribute to lipid A fatty acid heterogeneity in Porphyromonas gingivalis |
| Q33550582 | Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients |
| Q35048029 | Animals devoid of pulmonary system as infection models in the study of lung bacterial pathogens |
| Q33775744 | Characterization of bacterial contaminants in the air of a duck hatchery by cultivation based and molecular methods |
| Q55361255 | Combination antibiotics against Pseudomonas aeruginosa, representing common and rare cystic fibrosis strains from different Irish clinics. |
| Q60167660 | Draft Genome Sequences of Two Cystic Fibrosis Strains of Stenotrophomonas maltophilia, AU30115 and AU32848 |
| Q47915940 | Fournier's gangrene (necrotising fasciitis) complicated by renal and respiratory insufficiency: a case report |
| Q41475646 | Identification and characterization of a serious multidrug resistant Stenotrophomonas maltophilia strain in China |
| Q50436340 | Identification of Stenotrophomonas maltophilia strains isolated from environmental and clinical samples: a rapid and efficient procedure |
| Q36380464 | Identification of swine influenza A virus and Stenotrophomonas maltophilia co-infection in Chinese pigs |
| Q41720902 | In vitro interaction of Stenotrophomonas maltophilia with human monocyte-derived dendritic cells |
| Q37844340 | Innate immunity in the respiratory epithelium. |
| Q92324719 | Microbiology of Cystic Fibrosis Airway Disease |
| Q35124580 | Microbiome in cystic fibrosis: Shaping polymicrobial interactions for advances in antibiotic therapy. |
| Q40078486 | Molecular characterization of virulence determinants of Stenotrophomonas maltophilia strains isolated from patients affected by cystic fibrosis |
| Q45099898 | New strategies against Stenotrophomonas maltophilia: a serious worldwide intrinsically drug-resistant opportunistic pathogen |
| Q93375850 | Occurrence of Antibiotic-Resistant Bacteria in Therapy Pools and Surrounding Surfaces |
| Q33386217 | PCR-based rapid genotyping of Stenotrophomonas maltophilia isolates |
| Q33950924 | Phenotypic and genotypic characterization of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis: genome diversity, biofilm formation, and virulence. |
| Q35757702 | Preferential Use of Carbon Sources in Culturable Aerobic Mesophilic Bacteria of Coptotermes curvignathus's (Isoptera: Rhinotermitidae) Gut and Its Foraging Area |
| Q33877139 | Role of excessive inflammatory response to Stenotrophomonas maltophilia lung infection in DBA/2 mice and implications for cystic fibrosis |
| Q36421502 | Sensing gram-negative bacterial lipopolysaccharides: a human disease determinant? |
| Q35758913 | Shifts in bacterial communities of two Caribbean reef-building coral species affected by white plague disease. |
| Q92170120 | Stenotrophomonas maltophilia Differential Gene Expression in Synthetic Cystic Fibrosis Sputum Reveals Shared and Cystic Fibrosis Strain-Specific Responses to the Sputum Environment |
| Q90341632 | Stenotrophomonas maltophilia colonization during allogeneic hematopoietic stem cell transplantation is associated with impaired survival |
| Q53297625 | Stenotrophomonas maltophilia in cystic fibrosis: serologic response and effect on lung disease. |
| Q39274421 | Stenotrophomonas maltophilia outer membrane vesicles elicit a potent inflammatory response in vitro and in vivo. |
| Q35199103 | Stenotrophomonas maltophilia strains replicate and persist in the murine lung, but to significantly different degrees |
| Q37763019 | Stenotrophomonas maltophilia: Significant contemporary hospital pathogen - review |
| Q26995336 | Stenotrophomonas maltophilia: an emerging global opportunistic pathogen |
| Q34977790 | Stenotrophomonas maltophilia: an emerging opportunist human pathogen |
| Q37055211 | Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer |
| Q37866819 | Stenotrophomonas maltophilia: emerging disease patterns and challenges for treatment. |
| Q27675447 | Structure of Aminodeoxychorismate Synthase from Stenotrophomonas maltophilia |
| Q34987030 | The versatility and adaptation of bacteria from the genus Stenotrophomonas. |
| Q36053562 | Type II Secretion-Dependent Degradative and Cytotoxic Activities Mediated by Stenotrophomonas maltophilia Serine Proteases StmPr1 and StmPr2 |
Search more.